Paradigm’s Post

For those that have followed me over the last few decades in the industry you know my passion for ensuring we find ways to democratize access to best possible care for all patients. When we started Paradigm it was with this mission at the forefront - how do we entirely reimagine the clinical development ecosystem - not in an incremental way - but in a more punctuated equilibrium moment for the industry. A bold vision to create equitable access to clinical trials and best possible care for all providers and their patients - with the byproduct being faster and more efficient drug development. At Paradigm, we’ve spent the past year working at full speed to create health equity across all patient populations by building a new model for clinical trials. Today we announced that Bristol Myers Squibb, one of the leading pharmaceutical companies in the world, equally realizes the challenges with today’s status quo and wants to collaborate to address it. As we’ve put together this relationship, I’ve been struck by how everyone, across both companies, has reached a breaking point with the complexity of timelines to get new drugs to market and the fact that in that process, patients from the most important demographics and communities are often left out. We are thrilled to have a visionary partner like Bristol Myers Squibb share this goal with us! I know this will be the first of many such relationships as other biopharma companies realize how much faster and more effectively we can bring new, important drugs to market when everyone has the opportunity to participate in research. #BristolMyersSquibb #BMS #Paradigm #equitableaccess

⏰ One day left to register! 📆 Join Citeline's expert analysts June 12, as they dissect the major announcements, clinical trial results, and emerging therapies revealed at this year’s ASCO Annual Meeting. Here’s what you can expect: • Comprehensive highlights • Strategic analysis • Market implications • Licensing opportunities And a live Q&A, so you can hear from the experts as they answer your pressing questions on the future of oncology care. Register for the webinar today: https://ow.ly/T4SR50S8Ahr. #ASCOAnnualMeeting #MarketIntelligence #ClinicalTrials #OncologyTrends #WebinarAlert #OncologyInsights

Just Released: 2023 Community Oncology Annual Trend Report Take a deep dive into the most important trends occurring in community oncology practices, including use of clinical management tools, relationships with payers, and the competitive environment impacting practices. Download Now: https://lnkd.in/gmxSyeMG #marketaccess #marketaccessinsights #communityoncology

📈 Aiming to accelerate your site's oncology clinical trial accruals in 2024? 🔎 Realyze Intelligence allows you to effortlessly navigate the challenges of increasingly complex patient data & stringent inclusion criteria. ✅ Put more patients on better trials, faster. Curious how to start? Schedule time with us today : https://lnkd.in/gn5DsJkT #OncologySolutions #AIOncology #PrecisionOncology #AIinPrecisionOncology #ClinicalTrials #InnovationinClinicalTrials

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/ggX9mGUC #clinicaltrials #research #drugdevelopment

Check out part 2 in our 3-part series on how to optimize PMA outcomes for combinations while working within the current environmental constraints!

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/gsMyyaPP #clinicaltrials #research #drugdevelopment

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/dqeMG833 #clinicaltrials #research #drugdevelopment

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Take a look at our recent blog that explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/e8azDXJ4 #clinicaltrials #research #drugdevelopment Fortrea